The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective

Cara Lynn Kim,1 Ligia Maria Cruz Espinoza,1 Kirsten S Vannice,2 Birkneh Tilahun Tadesse,1,3,4 Ellis Owusu-Dabo,5 Raphaël Rakotozandrindrainy,6 Ilesh V Jani,7 Mekonnen Teferi,8 Abdramane Bassiahi Soura,9 Octavie Lunguya,10,11 A Duncan Steele,2 Florian Marks1,6,12,13 1International Vaccine Institute,...

Full description

Bibliographic Details
Main Authors: Kim CL, Cruz Espinoza LM, Vannice KS, Tadesse BT, Owusu-Dabo E, Rakotozandrindrainy R, Jani IV, Teferi M, Bassiahi Soura A, Lunguya O, Steele AD, Marks F
Format: Article
Language:English
Published: Dove Medical Press 2022-03-01
Series:Research and Reports in Tropical Medicine
Subjects:
Online Access:https://www.dovepress.com/the-burden-of-typhoid-fever-in-sub-saharan-africa-a-perspective-peer-reviewed-fulltext-article-RRTM
_version_ 1818282602116677632
author Kim CL
Cruz Espinoza LM
Vannice KS
Tadesse BT
Owusu-Dabo E
Rakotozandrindrainy R
Jani IV
Teferi M
Bassiahi Soura A
Lunguya O
Steele AD
Marks F
author_facet Kim CL
Cruz Espinoza LM
Vannice KS
Tadesse BT
Owusu-Dabo E
Rakotozandrindrainy R
Jani IV
Teferi M
Bassiahi Soura A
Lunguya O
Steele AD
Marks F
author_sort Kim CL
collection DOAJ
description Cara Lynn Kim,1 Ligia Maria Cruz Espinoza,1 Kirsten S Vannice,2 Birkneh Tilahun Tadesse,1,3,4 Ellis Owusu-Dabo,5 Raphaël Rakotozandrindrainy,6 Ilesh V Jani,7 Mekonnen Teferi,8 Abdramane Bassiahi Soura,9 Octavie Lunguya,10,11 A Duncan Steele,2 Florian Marks1,6,12,13 1International Vaccine Institute, Seoul, Republic of Korea; 2Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, WA, USA; 3Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; 4Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 5School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; 6University of Antananarivo, Antananarivo, Madagascar; 7Instituto Nacional de Saúde (INS), Maputo Province, Mozambique; 8Armauer Hansen Research Institute, Addis Ababa, Ethiopia; 9Institut Supérieur des Sciences de la Population, Université Joseph Ki-Zerbo de Ouagadougou, Ouagadougou, Burkina Faso; 10Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; 11Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo; 12Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; 13Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, GermanyCorrespondence: Florian Marks, Tel +82-2-881-1133, Email fmarks@ivi.intAbstract: While typhoid fever has largely been eliminated in high-income regions which have developed modern water, sanitation, and hygiene facilities, it remains a significant public health burden resulting in morbidity and mortality among millions of individuals in resource-constrained settings. Prevention and control efforts are needed that integrate several high-impact interventions targeting facilities and infrastructure, including those addressing improvements in sanitation, access to safe water, and planned urbanization, together with parallel efforts directed at effective strategies for use of typhoid conjugate vaccines (TCV). The use of TCVs is a critical tool with the potential of having a rapid impact on typhoid fever disease burden; their introduction will also serve as an important strategy to combat evolving antimicrobial resistance to currently available typhoid fever treatments. Well-designed epidemiological surveillance studies play a critical role in establishing the need for, and monitoring the impact of, typhoid fever control and prevention strategies implemented by public health authorities. Here, we present a perspective based on a narrative review of the impact of typhoid fever on morbidity and mortality in sub-Saharan Africa and discuss ongoing surveillance activities and the role of vaccination in prevention and control efforts.Keywords: typhoid, burden, mortality, sub-Saharan Africa, conjugate-vaccine, antimicrobial resistance
first_indexed 2024-12-13T00:23:37Z
format Article
id doaj.art-7f52f196a24047158232fbcfcedf1282
institution Directory Open Access Journal
issn 1179-7282
language English
last_indexed 2024-12-13T00:23:37Z
publishDate 2022-03-01
publisher Dove Medical Press
record_format Article
series Research and Reports in Tropical Medicine
spelling doaj.art-7f52f196a24047158232fbcfcedf12822022-12-22T00:05:29ZengDove Medical PressResearch and Reports in Tropical Medicine1179-72822022-03-01Volume 131973660The Burden of Typhoid Fever in Sub-Saharan Africa: A PerspectiveKim CLCruz Espinoza LMVannice KSTadesse BTOwusu-Dabo ERakotozandrindrainy RJani IVTeferi MBassiahi Soura ALunguya OSteele ADMarks FCara Lynn Kim,1 Ligia Maria Cruz Espinoza,1 Kirsten S Vannice,2 Birkneh Tilahun Tadesse,1,3,4 Ellis Owusu-Dabo,5 Raphaël Rakotozandrindrainy,6 Ilesh V Jani,7 Mekonnen Teferi,8 Abdramane Bassiahi Soura,9 Octavie Lunguya,10,11 A Duncan Steele,2 Florian Marks1,6,12,13 1International Vaccine Institute, Seoul, Republic of Korea; 2Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, WA, USA; 3Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; 4Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 5School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; 6University of Antananarivo, Antananarivo, Madagascar; 7Instituto Nacional de Saúde (INS), Maputo Province, Mozambique; 8Armauer Hansen Research Institute, Addis Ababa, Ethiopia; 9Institut Supérieur des Sciences de la Population, Université Joseph Ki-Zerbo de Ouagadougou, Ouagadougou, Burkina Faso; 10Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; 11Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo; 12Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; 13Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, GermanyCorrespondence: Florian Marks, Tel +82-2-881-1133, Email fmarks@ivi.intAbstract: While typhoid fever has largely been eliminated in high-income regions which have developed modern water, sanitation, and hygiene facilities, it remains a significant public health burden resulting in morbidity and mortality among millions of individuals in resource-constrained settings. Prevention and control efforts are needed that integrate several high-impact interventions targeting facilities and infrastructure, including those addressing improvements in sanitation, access to safe water, and planned urbanization, together with parallel efforts directed at effective strategies for use of typhoid conjugate vaccines (TCV). The use of TCVs is a critical tool with the potential of having a rapid impact on typhoid fever disease burden; their introduction will also serve as an important strategy to combat evolving antimicrobial resistance to currently available typhoid fever treatments. Well-designed epidemiological surveillance studies play a critical role in establishing the need for, and monitoring the impact of, typhoid fever control and prevention strategies implemented by public health authorities. Here, we present a perspective based on a narrative review of the impact of typhoid fever on morbidity and mortality in sub-Saharan Africa and discuss ongoing surveillance activities and the role of vaccination in prevention and control efforts.Keywords: typhoid, burden, mortality, sub-Saharan Africa, conjugate-vaccine, antimicrobial resistancehttps://www.dovepress.com/the-burden-of-typhoid-fever-in-sub-saharan-africa-a-perspective-peer-reviewed-fulltext-article-RRTMtyphoidburdenmortalitysub-saharan africaconjugate-vaccineantimicrobial resistance
spellingShingle Kim CL
Cruz Espinoza LM
Vannice KS
Tadesse BT
Owusu-Dabo E
Rakotozandrindrainy R
Jani IV
Teferi M
Bassiahi Soura A
Lunguya O
Steele AD
Marks F
The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective
Research and Reports in Tropical Medicine
typhoid
burden
mortality
sub-saharan africa
conjugate-vaccine
antimicrobial resistance
title The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective
title_full The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective
title_fullStr The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective
title_full_unstemmed The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective
title_short The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective
title_sort burden of typhoid fever in sub saharan africa a perspective
topic typhoid
burden
mortality
sub-saharan africa
conjugate-vaccine
antimicrobial resistance
url https://www.dovepress.com/the-burden-of-typhoid-fever-in-sub-saharan-africa-a-perspective-peer-reviewed-fulltext-article-RRTM
work_keys_str_mv AT kimcl theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT cruzespinozalm theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT vanniceks theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT tadessebt theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT owusudaboe theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT rakotozandrindrainyr theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT janiiv theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT teferim theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT bassiahisouraa theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT lunguyao theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT steelead theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT marksf theburdenoftyphoidfeverinsubsaharanafricaaperspective
AT kimcl burdenoftyphoidfeverinsubsaharanafricaaperspective
AT cruzespinozalm burdenoftyphoidfeverinsubsaharanafricaaperspective
AT vanniceks burdenoftyphoidfeverinsubsaharanafricaaperspective
AT tadessebt burdenoftyphoidfeverinsubsaharanafricaaperspective
AT owusudaboe burdenoftyphoidfeverinsubsaharanafricaaperspective
AT rakotozandrindrainyr burdenoftyphoidfeverinsubsaharanafricaaperspective
AT janiiv burdenoftyphoidfeverinsubsaharanafricaaperspective
AT teferim burdenoftyphoidfeverinsubsaharanafricaaperspective
AT bassiahisouraa burdenoftyphoidfeverinsubsaharanafricaaperspective
AT lunguyao burdenoftyphoidfeverinsubsaharanafricaaperspective
AT steelead burdenoftyphoidfeverinsubsaharanafricaaperspective
AT marksf burdenoftyphoidfeverinsubsaharanafricaaperspective